/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

days · browse · Enter similar · o open

Sources: the FDA rejected Neuralink's clinical trial application, citing dozens of issues to fix before human testing, like the device's removal and its battery

Musk has said his brain implant company, Neuralink, will make the paralyzed walk, the blind see and eventually turn people into cyborgs.

Reuters

Discussion

  • @briannawu Brianna Wu on x
    Wow, @elonmusk's public statements on this strongly suggested that FDA approval for human trials of Neuralink was all but a matter of paperwork! It's not like the man to serially lie and exaggerate to status of his products to https://www.reuters.com/...... https://twitter.com/..…
  • @johnvoelcker John Voelcker on x
    The CEO of brain implant company Neuralink says it will make the paralyzed walk, the blind see + turn people into cyborgs. A @Reuters report shows the firm still struggles to secure clinical-trial approval for a modest goal: helping disabled people type. https://www.reuters.com/.…
  • @sokane1 Sean O'Kane on x
    “In explaining the decision to Neuralink, the agency outlined dozens of issues the company must address before human testing, a critical milestone on the path to final product approval, the staffers said.” https://www.reuters.com/...